The p53 tumor suppressor protein is a critical regulator of cell cycle progression that responds to DNA damage and certain other cellular stresses by arresting cell cycle progression or by inducing apoptosis (1) (2) (3) . These responses are important for preserving the integrity of the genome of a cell, thus preventing the transformation of a normal cell into a tumor cell. p53 normally is a short-lived protein that is maintained at low levels in unstressed cells. After cells are exposed to DNAdamaging agents, nucleotide depletion, or hypoxia, the p53 protein is transiently stabilized and accumulates in the nucleus. DNA damage also activates p53 as a transcription factor, which in turn induces or represses the transcription of several genes, including WAF1 and MDM2, that regulate cell cycle progression. Both stabilization of the p53 protein and activation of its sequence-specific DNA binding ability are widely believed to be mediated, at least in part, by post-translational modifications to the p53 protein. p53 is phosphorylated on several sites in its N-terminal transactivation domain as well as on several sites in the C-terminal tetramerization/regulatory domain (4) , and recent studies have shown that serines 15, 33, and 37 become phosphorylated after cells are exposed either to ionizing radiation (IR) 1 or to UV light (5) (6) (7) . In undamaged cells, p53 levels are low because the protein is rapidly degraded through a ubiquitin-mediated pathway (8, 9) that is mediated by the Mdm2, a protein that binds to the N terminus of p53 (10, 11) and serves as an ubiquitin ligase (12) . Recently, it was reported that incubating p53 with DNA-PK, a protein kinase activated by DNA strand breaks that phosphorylates human p53 in vitro on both Ser 15 and Ser 37 (13) , inhibited the binding of p53 to Mdm2 (5, 12, 14) . Thus, phosphorylation of these sites in vivo may stabilize p53 by preventing Mdm2 binding.
To test this prediction, we measured the binding constant for peptides corresponding to the N terminus of p53 and a human Mdm2 fragment that binds p53 (11) . Surprisingly, phosphorylation of Ser 15 , of Ser 37 , or of both residues had only a small effect on the binding constant. Hence, either the inhibition of p53-Mdm2 binding by DNA-PK was not due to its phosphorylation of p53 or the observed effects were an indirect consequence of that phosphorylation. Here, we show that the latter explanation may be correct. We demonstrate that phosphorylation of Thr 18 of p53 by casein kinase 1 (CK1) or a CK1-like activity is activated by phosphorylation of Ser 15 and that this phosphorylation can account, in part, for the inhibition of p53 binding by Mdm2 observed after exposing cells to ionizing radiation.
EXPERIMENTAL PROCEDURES
Cells and Cell Transfections-A549 (ATCC CCL-185), a human lung carcinoma cell line that expresses wild-type p53, was obtained from the American Type Culture Collection (Manassas, VA); NCI-H1299 (ATCC CRL-5803), a human lung carcinoma cell line that is null for both p53 alleles (15) , was obtained from A. Fornace, Jr. (NCI, National Institutes of Health). Cells were grown to 50 -70% confluency in Dulbecco's modified minimal essential medium supplemented with 10% fetal bovine serum and 100 nM glutamine in 150-mm dishes. Cultures were transfected with 10 g of DNA/plate by the LipofectAMINE Plus procedure as described by the manufacturer (Life Technologies, Inc.). One day * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ The first two authors contributed equally to this work. ¶ Supported in part by The Japan Securities Scholarship Foundation. Cs irradiator or treated with ALLN, a proteasome inhibitor, as described (7) . After the times indicated (see Fig. 3 ), cultures were harvested and processed for immunoprecipitation and immunoblotting.
Phosphorylation-specific p53 Antibodies-Antibodies specific for p53 phosphorylated at Thr 18 or Ser 20 were prepared as described (7) . Briefly, the PabSer(P)20 and PabThr(P)18 antibodies were made by immunizing rabbits with the p53 phosphopeptides Ac-15-26(20P)C (i.e. Ac-Ser-Gln-Glu-ThrPhe-Ser(P)-Asp-Leu-Trp-Lys-Leu-Leu-Cys-NH 2 ) or Ac-13-24(15, 18P)C (i.e. Ac-Pro-Leu-Ser(P)-Gln-Glu-Thr(P)-Phe-Ser-Asp-Leu-Trp-Lys-Cys-NH 2 ) coupled to keyhole limpet hemocyanin, respectively. Phosphorylation sitespecific antibodies were affinity purified from the resulting serum using the corresponding phosphorylated peptides attached to SulfoLink (Pierce). In the case of PabThr(P)18, the antibody was depleted of Ser 15 (P) cross-reacting activity by also passing the preparation through a column of Ac-p53 (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) Measurement of p53-Mdm2 Dissociation Constants-The dissociation constants (K d ) for unlabeled p53 peptides from the Mdm2 fragment were determined by a competition assay with fluorescein-labeled p53 (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) in 25 mM MES, pH6.8, 100 mM NaCl, 0.5 mM EDTA containing 0.1 mg/ml bovine serum albumin at 4°C (17, 18) . Fluorescence anisotropy was measured in a PanVera Beacon 2000 instrument with temperature control (PanVera Corporation, Madison, WI). Binding constants were determined as follows. The binding constant of the labeled peptide was first determined by titrating 50 nM fluorescein-labeled p53 (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) with increasing amounts of Mdm2 and measuring the fluorescence anisotropy at each concentration. In separate experiments, 50 nM of fluorescein labeled p53 (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) was mixed with several different concentrations of unlabeled peptides, and these mixtures were titrated with the Mdm2 fragment. Fluorescence anisotropy was recorded at each concentration.
The binding constant of the fluoresceinated p53 (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) peptide was determined by fitting to a single site binding equation using either SigmaPlot (SPSS Inc., San Rafael, CA) or a BASIC program written by the authors. For the competition assays, binding isotherms at three concentrations were simultaneously fitted by a global-fit program developed by the authors to the following equations.
A f is the anisotropy of the free labeled peptide, A c is the anisotropy of the labeled peptide-Mdm2 complex, A obs is the observed anisotropy, K* is the association constant of the labeled peptide with the Mdm2 fragment, K is the association constant of the unlabeled peptide with the Mdm2 fragment, [P*] T is the total concentration of labeled peptide, [P] T is the total concentration of unlabeled competing peptide, [P*M] is the concentration of the labeled peptide-Mdm2 complex, and [M] T is the total concentration of Mdm2 fragment. These equations were derived from the Weber average formula (19) and the mass action law, assum- (20) , containing residues 2-47 of human p53, at 38 M was incubated at 30°C for 30 min with DNA-PK (Promega) in 50 mM Hepes, pH 7.5, 50 mM KCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 200 M ATP, and 10 g/ml calf thymus DNA. The reactants then were diluted into an equal volume of a CK1-␦ reaction as described above, but without peptide, and incubation was continued for an additional 30 min. Phosphoamino acid analysis was performed as described (21) .
Detection of p53 Phosphorylation by Western Immunoblotting-Cell extracts were prepared, and Western immunoblots were performed essentially as described (7); however, in place of immunoprecipitation with protein G-Sepharose, p53 was collected by centrifugation with a 1:1 mixture of PAb1801-and DO-1-agarose beads (Santa Cruz Biotechnology, Inc.). 5 g of each antibody conjugate was used for 1300 g of extract protein; after incubation for 2 h at 4°C, the beads were washed five times by centrifugation. To avoid possible interference by the IgG heavy chain, the reducing agent was omitted from the SDS-polyacrylamide gel electrophoresis sample buffer.
RESULTS
Interaction of p53 and Mdm2 )-To examine directly the effect of N-terminal phosphorylation on the interaction of p53 and Mdm2, we determined the dissociation constants for various phosphorylated p53(1-39) peptides with Mdm2(17-125) by measuring the changes in fluorescence anisotropy of fluorescein-labeled p53 (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) complexed with Mdm2(17-125) in response to added p53(1-39) ( Fig. 1 and Table I ). Different amounts of Mdm2 were added to mixtures of the fluorescein-labeled probe and p53(1-39) or p53(1-39) phosphorylated at different positions. The dissociation constant for each peptide with Mdm2 then was determined by fitting the curves using a mathematical model (see "Experimental Procedures"). Unphosphorylated p53(1-39) bound Mdm2 with an apparent dissociation constant of 70 Ϯ 20 nM (Fig. 1A) , whereas p53(1-39) with Ala-Ala replacing Leu 22 -Trp 23 exhibited no measurable binding (Fig. 1D) . Surprisingly, p53(1-39) phosphorylated on Ser 15 ( Fig. 1B) , on Ser 37 or on both residues had dissociation constants that were only slightly higher (60 -260 nM) on average than the unphosphorylated peptide (Table I) 1C ) dramatically reduced the association (ϳ30 -50-fold). Contrary to previous reports, these data suggest that phosphorylation of p53 at Ser 15 and Ser 37 does not directly inhibit formation of the p53-Mdm2 complex; rather, phosphorylation of Thr 18 , which stabilizes the association with Mdm2 through hydrogen bonding of the threonine hydroxyl group (11), appears to be crucial.
Phosphorylation of Thr 18 in Vivo in Response to Ionizing Radiation-To explore the question of its phosphorylation, we prepared an antibody that specifically recognizes p53 only when it is phosphorylated on Thr 18 ; we also made antibodies that recognize p53 only when it is phosphorylated on Ser 15 or on Ser 20 . The specificities of these antibodies for p53 phosphorylated at the respective sites were confirmed by peptide enzyme-linked immunosorbent assays and/or by peptide dot-blot assays as reported recently for other p53 phosphorylation-specific antibodies (7). Fig. 2 Fig. 3 shows that p53 Thr 18 was not detectably phosphorylated in unirradiated A549 cells nor in cells treated with the proteasome inhibitor ALLN, which stabilizes p53 (22) , as seen with DO-1, a monoclonal antibody specific for the N terminus of p53. However, after cells were exposed to 8 gray of ␥-irradiation, a dramatic, transient phosphorylation of Thr 18 was observed by 45 min that peaked 2 h after exposure and disappeared between 8 and 24 h. Ser 20 also was phosphorylated after IR with similar initial kinetics, but it remained phosphorylated at 24 h. As shown previously (5, 6), phosphorylation of Ser 15 is rapidly induced by IR and was seen within 45 min of exposure; phosphorylation peaked at 2 h and then slowly declined (Fig.  3) CK1 (23, 24) , a ubiquitously expressed protein kinase, the specificity of which can be directed to specific serines and threonines by phosphorylation at the Ϫ3 position (25) (26) (27) . CK1 also prefers a hydrophobic residue at the ϩ1 position. 18 is the major target for phosphorylation by CK1 (Fig. 4B) . Phosphorylation of Thr 18 also was potentiated by prior phosphorylation of an N-terminal p53 fusion protein with DNA-PK (Fig. 4C) . Data points were determined in triplicate and fitted to a set of equations as described under "Experimental Procedures" to determine the apparent dissociation constant (K d ) for the competitor peptide-Mdm2(17-125) complex. Similar experiments were performed to determine dissociation constants for other peptides described in Table I . (Fig. 5) . In contrast, Ser 20 was phosphorylated in both mutants. No phosphorylation signal was observed from cells transfected with the vector alone. In contrast to endogenous p53 in A549 cells (Fig. 3) , phosphorylation of p53 at Ser 20 and Thr 18 in transfected cells was only stimulated by and not dependent on the intentionally applied DNA damage (Fig. 5) . We believe that in this case phosphorylation may be induced by the process of transfection or by DNA breaks present in the transfected DNA (29) .
DISCUSSION
In vitro, Ser 15 can be phosphorylated by DNA-PK (13) and ATM (20, 30, 31) , a related protein kinase that is missing or defective in people with ataxia telangiectasia (32) . In vivo efficient phosphorylation of Ser 15 after exposing cells to IR requires a functional ATM gene (6) , and in ATM-deficient cells, the accumulation of p53 in response to IR also is delayed (33) , suggesting that phosphorylation of Ser 15 is important for stabilizing p53. An important mechanism that regulates p53 stability is its binding to Mdm2, which targets p53 for ubiquitinmediated degradation. In contrast to other reports (5, 12, 14, 34), our data suggest that Ser 15 phosphorylation indirectly affects the association of p53 with Mdm2 rather than directly (Fig. 6) . Compared with the unphosphorylated peptide, the association of p53 N-terminal peptides phosphorylated at Ser 15 , Ser 37 , or both, with Mdm2(17-125) was barely reduced. Importantly, however, this association was dramatically inhibited by phosphorylation at Thr 18 (Table I ). The crystal structure of Mdm2 with the N terminus of p53 shows that p53 residues 18 -26 form an amphipathic helix that fits into a deep hydrophobic groove in the Mdm2 structure (11) . Hydrogen bonds made by the side chain hydroxyl of Thr 18 with a backbone amide and the side chain carboxyl group of Asp 21 of p53 contribute to stabilizing the helical structure of this segment. Phosphorylation of Thr 18 would eliminate these bonds and introduce a charge-charge repulsion with Asp 21 that would further destabilize the p53-Mdm2 interaction. In contrast, Ser 15 and Ser 37 lie outside the region of direct contact determined from the crystal structure. Thus, structural considerations support a role for Thr 18 phosphorylation in inhibiting the association between p53 and Mdm2. While this report was in preparation, Böttger et al. (35) reported that phosphorylation of Thr 18 or replacement of this threonine by amino acids other than serine substantially decreased the interaction of p53 N-terminal peptides with GST-Mdm2, in agreement with the results reported here. Moreover, Craig et al. (34) recently reported that monoclonal antibodies specific for phosphorylated Thr 18 detected p53 in human breast cancers with elevated p53. They also found that a peptide phosphorylated at Thr 18 inhibited p53 binding by Mdm2.
CK1-␦ and CK1-⑀ are closely related, ubiquitously expressed mammalian homologs of budding yeast Hrr25, a nuclear Ser/ Thr protein kinase that was isolated in a screen for mutants sensitive to double-stranded breaks (36 -38) . Yeast HRR25 mutants are defective in the transcriptional induction of a subset of DNA damage-inducible genes that require Swi6, a transcription factor phosphorylated by Hrr25 in vitro (39) . Murine CK1 phosphorylates several residues at the N terminus of mouse p53 (23, 24) , but these residues are not completely conserved in human p53, and our attempts to phosphorylate the N terminus of unmodified human p53 with recombinant CK1-␦ were unsuccessful (Fig. 4) . In contrast to unmodified p53, p53 (Fig. 3) , and this time course is not completely coincident with p53 accumulation. Recently, Ashcroft et al. (40) and Blattner et al. (41) reported that p53 mutated to change several phosphorylation sites including Thr 18 to alanine is still stabilized after exposure to DNA damage-inducing agents. We therefore postulate that DNA damage-induced modifications to Mdm2 (42) or other components of the targeting system may contribute to stabilizing p53. Furthermore, transfection of HCT-116 p53
Ϫ/Ϫ cells with increasing amounts of Mdm2 expressing plasmid did not differentially affect the stability of wild-type p53 compared with p53-S15A or p53-T18A (data not shown). Thus, under these conditions, phosphorylation of Thr 18 is not the dominant regulator of p53 stability. Given the central role of p53 in integrating stress-related signals and the apparent multiple mechanisms of activating p53 sequence-specific DNA binding (2, 3) , the existence of redundant mechanisms for stabilizing p53 would not be surprising. In other cell types or under other -1-24) . B, two-dimensional phosphoamino acid analysis of the p53(Ac-1-24(15P) peptide after incubation with CK1-␦. The positions of inorganic phosphate (Pi), phosphoserine (Ser(P)), phosphothreonine (Thr(P)), and the origin (ϫ) are shown. C, a human p53(2-46)-human Oct-1 Pou-domain fusion protein was incubated with DNA-PK, CK1, or both, and the products were analyzed by immunoblotting with DO-1 or phosphorylation-specific antibodies as indicated.
FIG. 5. Phosphorylation of p53 Thr
18 requires Ser 15 . H1299 cells were transfected with 10 g/plate of vector (vec), pC53-SN3, which expresses wild-type human p53 (43) or p53-S15A or p53-S37A (28) . One day after transfection one set of cultures were exposed to 8 gray of IR; both sets were harvested for Western immunoblot analysis 2 h later. The antibodies used to detect p53 are indicated at the left.
FIG. 6. Model for inhibition of Mdm2 binding to p53 by Ser
15 -mediated phosphorylation of Thr 18 by CK1. Human p53 becomes rapidly phosphorylated after cells are exposed to ionizing radiation (Fig. 3) , possibly by ATM (20, 30 18 , or of other residues also may potentiate or inhibit interaction of p53 with other proteins that bind to its N terminus including RPA, TFIIH, JNK, and p300.
circumstances, phosphorylation of Thr 18 could play a more important role. Phosphorylation of Thr 18 and other sites at the N terminus of p53 also may regulate the interaction of p53 with other cellular proteins, such as CBP/p300, TFIIH, the TAFs, RPA, and JNK (Fig. 6) , and in many cells, the regulation of such interactions may be more important. Investigations of these possibilities are in progress.
